{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:17:13Z","timestamp":1790083033497,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Dr. Reddy's Laboratories"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s40119-021-00217-7","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T11:03:49Z","timestamp":1617879829000},"page":"255-269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effectiveness of Telmisartan on Blood Pressure Control in Hypertensive Patients in India: A Real-World Retrospective Study from Electronic Medical Records"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-9909","authenticated-orcid":false,"given":"Mohammed Yunus","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucheta","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabir","family":"Abdulkutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Navasundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash Kumar","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amey","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyog","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"217_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","volume":"129","author":"SE Kjeldsen","year":"2018","unstructured":"Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95\u20139.","journal-title":"Pharmacol Res"},{"key":"217_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ihj.2019.09.012","volume":"71","author":"S Ramakrishnan","year":"2019","unstructured":"Ramakrishnan S, Zachariah G, Gupta K, Shivkumar Rao J, Mohanan PP, Venugopal K, et al. Prevalence of hypertension among Indian adults: results from the great India blood pressure survey. Indian Heart J. 2019;71:309\u201313.","journal-title":"Indian Heart J"},{"key":"217_CR3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1186\/s12889-018-5806-x","volume":"18","author":"A Gheorghe","year":"2018","unstructured":"Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018;18:975.","journal-title":"BMC Public Health"},{"key":"217_CR4","first-page":"389","volume":"7","author":"LC Paramore","year":"2001","unstructured":"Paramore LC, Halpern MT, Lapuerta P, Hurley JS, Frost FJ, Fairchild DG, et al. Impact of poorly controlled hypertension on healthcare resource utilization and cost. Am J Manag Care. 2001;7:389\u201398.","journal-title":"Am J Manag Care"},{"key":"217_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/HJH.0000000000000146","volume":"32","author":"R Anchala","year":"2014","unstructured":"Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32:1170\u20137.","journal-title":"J Hypertens"},{"key":"217_CR6","doi-asserted-by":"publisher","first-page":"e1002801","DOI":"10.1371\/journal.pmed.1002801","volume":"16","author":"J Prenissl","year":"2019","unstructured":"Prenissl J, Manne-Goehler J, Jaacks LM, Prabhakaran D, Awasthi A, Bischops AC, et al. Hypertension screening, awareness, treatment, and control in India: A nationally representative cross-sectional study among individuals aged 15 to 49 years. PLoS Med. 2019;16:e1002801.","journal-title":"PLoS Med"},{"key":"217_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507\u201320.","journal-title":"JAMA"},{"key":"217_CR8","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269\u2013324.","journal-title":"Hypertension"},{"key":"217_CR9","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"217_CR10","first-page":"8","volume":"67","author":"I AoPo","year":"2019","unstructured":"AoPo I. Indian guidelines on hypertension-IV 2019. J Assoc Physicians India. 2019;67:8\u201346.","journal-title":"J Assoc Physicians India"},{"key":"217_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/jpcs.jpcs_7_17","volume":"3","author":"S Ramakrishnan","year":"2017","unstructured":"Ramakrishnan S, Ingole S, Dey A, Jain R. Management of hypertension: Insights into prescribing behavior with focus on angiotensin receptor blockers. J Pract Cardiovasc Sci. 2017;3:22\u20137.","journal-title":"J Pract Cardiovasc Sci"},{"key":"217_CR12","first-page":"2380","volume":"6","author":"R Gupta","year":"2018","unstructured":"Gupta R, Malhotra A, Malhotra P. Study of prescribing pattern of drugs used in the treatment of hypertension in a tertiary care teaching hospital in North India: an observational study Int J Res. Med Sci. 2018;6:2380\u20134.","journal-title":"Med Sci"},{"key":"217_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5455\/2319-2003.ijbcp20140409","volume":"3","author":"M Cidda","year":"2014","unstructured":"Cidda M, Mateti UV, Batchu MK, Martha S. Study of prescribing patterns of antihypertensives in South Indian population. Int J Basic Clin Pharmacol. 2014;3:303\u20137.","journal-title":"Int J Basic Clin Pharmacol"},{"key":"217_CR14","doi-asserted-by":"publisher","first-page":"922","DOI":"10.5455\/ijmsph.2014.170420146","volume":"3","author":"MA Beg","year":"2014","unstructured":"Beg MA, Dutta S, Varma A, Kant R, Bawa S, Anjoom M, et al. A study on drug prescribing pattern in hypertensive patients in a tertiary care teaching hospital at Dehradun. Uttarakhand Int J Med Sci Public Health. 2014;3:922\u20136.","journal-title":"Uttarakhand Int J Med Sci Public Health"},{"key":"217_CR15","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.18203\/2320-6012.ijrms20164046","volume":"4","author":"R Romday","year":"2016","unstructured":"Romday R, Gupta AK, Bhambani P. An assessment of antihypertensive drug prescription patterns and adherence to joint national committee-8 hypertension treatment guidelines among hypertensive patients attending a tertiary care teaching hospital. Int J Res Med Sci. 2016;4:5125\u201333.","journal-title":"Int J Res Med Sci"},{"key":"217_CR16","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.14260\/jemds\/2015\/302","volume":"4","author":"S Patta","year":"2015","unstructured":"Patta S. Drug utilization pattern of antihypertensives in geriatric and non-geriatric population in a tertiary care Government Hospital Srikakulum, A.P. J Evol Med Dental Sci. 2015;4:2101\u20136.","journal-title":"J Evol Med Dental Sci"},{"key":"217_CR17","first-page":"106","volume":"8","author":"M Kalikar","year":"2017","unstructured":"Kalikar M, Nivangune KS, Dakhale GN, Bajait CS, Sontakke SD, Motghare VM, et al. Efficacy and tolerability of olmesartan, telmisartan, and losartan in patients of stage i hypertension: a randomized. Open-label Study J Pharmacol Pharmacother. 2017;8:106\u201311.","journal-title":"Open-label Study J Pharmacol Pharmacother"},{"key":"217_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1871530314666141128154152","volume":"15","author":"PN Gore","year":"2015","unstructured":"Gore PN, Badar VA, Hardas MM, Bansode VJ. Comparative effect of telmisartan vs lisinopril on blood pressure in patients of metabolic syndrome. Endocr Metab Immune Disord Drug Targets. 2015;15:64\u201370.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"217_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/picr.PICR_93_17","volume":"9","author":"P Gadge","year":"2018","unstructured":"Gadge P, Gadge R, Paralkar N, Jain P, Tanna V. Effect of telmisartan on blood pressure in patients of type 2 diabetes with or without complications. Perspect Clin Res. 2018;9:155\u201360.","journal-title":"Perspect Clin Res"},{"key":"217_CR20","first-page":"730","volume":"107","author":"AF Arif","year":"2009","unstructured":"Arif AF, Kadam GG, Joshi C. Treatment of hypertension: postmarketing surveillance study results of telmisartan monotherapy, fixed dose combination of telmisartan + hydrochlorothiazide\/amlodipine. J Indian Med Assoc. 2009;107:730\u20133.","journal-title":"J Indian Med Assoc"},{"key":"217_CR21","doi-asserted-by":"publisher","first-page":"d2304","DOI":"10.1136\/bmj.d2304","volume":"343","author":"DG Altman","year":"2011","unstructured":"Altman DG, Bland JM. How to obtain the P value from a confidence interval. BMJ. 2011;343:d2304.","journal-title":"BMJ"},{"key":"217_CR22","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1177\/147323000903700602","volume":"37","author":"M Burnier","year":"2009","unstructured":"Burnier M. Telmisartan: a different angiotensin II receptor blocker protecting a different population? J Int Med Res. 2009;37:1662\u201379.","journal-title":"J Int Med Res"},{"key":"217_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40264-014-0239-7","volume":"38","author":"HM Abraham","year":"2015","unstructured":"Abraham HM, White CM, White WB. The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf. 2015;38:33\u201354.","journal-title":"Drug Saf"},{"key":"217_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/147323000303100613","volume":"31","author":"C Ingino","year":"2003","unstructured":"Ingino C, Farsang C, Laucevicius A, Bergovec M. An open-label study investigating the efficacy and safety of 12\u201396 weeks of telmisartan treatment in patients with hypertension. J Int Med Res. 2003;31:561\u201374.","journal-title":"J Int Med Res"},{"key":"217_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2165\/00002018-200427050-00005","volume":"27","author":"MC Michel","year":"2004","unstructured":"Michel MC, Bohner H, Koster J, Schafers R, Heemann U. Safety of telmisartan in patients with arterial hypertension: an open-label observational study. Drug Saf. 2004;27:335\u201344.","journal-title":"Drug Saf"},{"key":"217_CR26","doi-asserted-by":"publisher","first-page":"8387613","DOI":"10.1155\/2018\/8387613","volume":"2018","author":"S Farsky","year":"2018","unstructured":"Farsky S, Striskova A, Borcin M. Hypertension treatment in patients with metabolic syndrome and\/or type 2 diabetes mellitus: analysis of the therapy effectivity and the therapeutic inertia in outpatient study. Cardiol Res Pract. 2018;2018:8387613.","journal-title":"Cardiol Res Pract"},{"key":"217_CR27","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0149-2918(04)80049-3","volume":"26","author":"G Derosa","year":"2004","unstructured":"Derosa G, Cicero AF, Bertone G, Piccinni MN, Fogari E, Ciccarelli L, et al. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study. Clin Ther. 2004;26:1228\u201336.","journal-title":"Clin Ther"},{"issue":"612\u20134","key":"217_CR28","first-page":"624","volume":"106","author":"AA Faruqui","year":"2008","unstructured":"Faruqui AA. Evaluation of safety and efficacy of telmisartan-amlodipine combination in treating hypertension. J Indian Med Assoc. 2008;106(612\u20134):624.","journal-title":"J Indian Med Assoc"},{"issue":"676\u2013691","key":"217_CR29","first-page":"e1","volume":"40","author":"GC Oh","year":"2018","unstructured":"Oh GC, Han JK, Han KH, Hyon MS, Doh JH, Kim MH, et al. Efficacy and safety of fixed-dose combination therapy with telmisartan and rosuvastatin in korean patients with hypertension and dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study. Clin Ther. 2018;40(676\u2013691):e1.","journal-title":"Clin Ther"},{"key":"217_CR30","doi-asserted-by":"publisher","first-page":"e642","DOI":"10.1097\/MJT.0000000000000733","volume":"25","author":"Y Wang","year":"2018","unstructured":"Wang Y, Qiao S, Han DW, Rong XR, Wang YX, Xue JJ, et al. Telmisartan improves insulin resistance: a meta-analysis. Am J Ther. 2018;25:e642\u201351.","journal-title":"Am J Ther"},{"key":"217_CR31","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","volume":"43","author":"SC Benson","year":"2004","unstructured":"Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension. 2004;43:993\u20131002.","journal-title":"Hypertension"},{"key":"217_CR32","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1185\/03007995.2016.1171204","volume":"32","author":"GJ Choi","year":"2016","unstructured":"Choi GJ, Kim HM, Kang H, Kim J. Effects of telmisartan on fat distribution: a meta-analysis of randomized controlled trials. Curr Med Res Opin. 2016;32:1303\u20139.","journal-title":"Curr Med Res Opin"},{"key":"217_CR33","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.ijcard.2012.04.058","volume":"167","author":"Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T, Group A","year":"2013","unstructured":"Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T, Group A. Effects of telmisartan on proteinuria or albuminuria: a meta-analysis of randomized trials. Int J Cardiol. 2013;167:1443\u20139.","journal-title":"Int J Cardiol"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-021-00217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-021-00217-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-021-00217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T20:57:21Z","timestamp":1698872241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-021-00217-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1007\/s40119-021-00217-7","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}